Publication: 4643

Publication: 4643

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 43 (21) 2398-2408

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 14

Parents:: 4565
Children:: None

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:: EMD Serono
Grants:: U10CA180821, U10CA180882; U24CA196171; UG1CA189856, UG1CA189869, UG1CA232760, UG1CA233160, UG1CA233193, UG1CA233180, UG1CA233184, UG1CA233247, UG1CA233290, UG1CA233327, UG1CA233329, U10CA180868 (NRG Oncology); U10CA180888 (SWOG);

Corr. Author:
Authors:: Dan P Zandberg Jacob B Allred Ari J Rosenberg John M Kaczmar Paul Swiecicki Ricklie A Julian Andrew S Poklepovic Jessica R Bauman Minh D Phan Nabil F Saba Edgardo Rivera Kendrith Rowland Diwakar Davar Julia Cordes Alan L Ho Miao Zhang Stephanie A Berg Pamela N Munster Gary K Schwartz

Networks:: CA824, CARLE, LAPS-IL057, LAPS-MA036, LAPS-MI014, LAPS-MN026, LAPS-NY016, LAPS-OK003, LAPS-PA015, MUSC, NCRF, OH029, VCU

Study: Alliance-A091802
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: